Test environment running 7.6.6

Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds

dc.contributor.authorHolland, E. A.en
dc.contributor.authorBeaten, S. C.en
dc.contributor.authorBecker, T. M.en
dc.contributor.authorGrulet, O. M.C.en
dc.contributor.authorPeters, B. A.en
dc.contributor.authorRizos, H.en
dc.contributor.authorKefford, R. F.en
dc.contributor.authorMann, G. J.en
dc.date.accessioned2025-03-28T06:23:45Z
dc.date.available2025-03-28T06:23:45Z
dc.date.issued1995en
dc.description.abstractCDKN2 has been implicated as a melanoma susceptibility gene in some kindreds with a family history of this disease. Mutation analysis of CDKN2 in 17 familial melanoma Australian kindreds revealed a paucity of exon mutations and none of the previously described disease-related mutations. One novel germline mutation was found in exon one, Arg24Pro, which segregates with melanoma in 1/17 kindreds, Two previously described polymorphisms, Ala148Thr and a base change at nucleotide 540 were detected and one novel polymorphism in the untranslated region of exon 3 (nucleotide 580) was also found. Together with other recent reports, these findings provide support for CDKN2 as a susceptibility locus for familial melanoma but suggest that other loci are involved in some hereditary melanoma kindreds.en
dc.description.statustrueen
dc.format.extent6en
dc.identifier.otherScopus:0029562169en
dc.identifier.otherPubMed:8570179en
dc.identifier.urihttps://dspace-test.anu.edu.au/handle/1885/733743581
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=0029562169&partnerID=8YFLogxKen
dc.language.isoEnglishen
dc.sourceOncogeneen
dc.subjectCDKN2en
dc.subjectCyclin dependent kinase inhibitoren
dc.subjectFamilial melanomaen
dc.subjectMutation linkageen
dc.subjectp16en
dc.titleAnalysis of the p16 gene, CDKN2, in 17 Australian melanoma kindredsen
dc.typeArticleen
local.bibliographicCitation.lastpage2294en
local.bibliographicCitation.startpage2289en
local.contributor.affiliationHolland, E. A.; University of Sydneyen
local.contributor.affiliationBeaten, S. C.; University of Sydneyen
local.contributor.affiliationBecker, T. M.; University of Sydneyen
local.contributor.affiliationGrulet, O. M.C.; University of Sydneyen
local.contributor.affiliationPeters, B. A.; University of Sydneyen
local.contributor.affiliationRizos, H.; University of Sydneyen
local.contributor.affiliationKefford, R. F.; University of Sydneyen
local.contributor.affiliationMann, G. J.; University of Sydneyen
local.identifier.citationvolume11en
local.identifier.pureca6f4d91-f1b1-4a51-91b7-5adebed14073en
local.type.statusPublisheden

Downloads